In addition, high expression of YTHDF2 in HCC correlates with clinical factors of poor prognosis (high clinical stage, histological grade, and T grade) and negatively correlates with OS and recurrence-free survival (RFS) after curative surgery [100,102]. This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.